Journal List > Korean Circ J > v.40(4) > 1016536

TOOLS
Cheung: Arterial Stiffness in the Young: Assessment, Determinants, and Implications
Review
Korean Circulation Journal

Korean Circulation Journal 2010; 40(4): 153-162.

Published online: 22 April 2010

DOI: https://doi.org/10.4070/kcj.2010.40.4.153

Arterial Stiffness in the Young: Assessment, Determinants, and Implications

Yiu-Fai Cheung, MD

Division of Paediatric Cardiology, Department of Paediatrics and Adolescent Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China.

Correspondence: Yiu-Fai Cheung, MD, Division of Paediatric Cardiology, Department of Paediatrics and Adolescent Medicine, Queen Mary Hospital, The University of Hong Kong, Pokfulam Road, Hong Kong, China. Tel: 852-2255-4090, Fax: 852-2553-9491, xfcheung@hku.hk

Copyright © 2010 The Korean Society of Cardiology

(open-access):

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Arterial stiffness describes the rigidity of the arterial wall. Its significance owes to its relationship with the pulsatile afterload presented to the left ventricle and its implications on ventricular-arterial coupling. In adults, the contention that arterial stiffness as a marker and risk factor for cardiovascular morbidity and mortality is gaining support. Noninvasive methods have increasingly been adopted in both the research and clinical arena to determine local, segmental, and systemic arterial stiffness in the young. With adoption of these noninvasive techniques for use in children and adolescents, the phenomenon and significance of arterial stiffening in the young is beginning to be unveiled. The list of childhood factors and conditions found to be associated with arterial stiffening has expanded rapidly over the last decade; these include traditional cardiovascular risk factors, prenatal growth restriction, vasculitides, vasculopathies associated with various syndromes, congenital heart disease, and several systemic diseases. The findings of arterial stiffening have functional implications on energetic efficiency, structure, and function of the left ventricle. Early identification of arterial dysfunction in childhood may provide a window for early intervention, although longitudinal studies are required to determine whether improvement of arterial function in normal and at-risk paediatric populations will be translated into clinical benefits.

Keywords: Arteriosclerosis, Children

Introduction

Arterial stiffness, in simple terms, describes the rigidity of the arterial wall. It is primarily determined by structural components of the arterial wall, vascular smooth muscle tone, and transmural distending pressure.1) Increasing evidence suggests a role of the endothelium in the regulation of arterial stiffness through the release of vasoactive mediators that affect smooth muscle tone.
The significance of arterial stiffness owes to its direct relationship with the characteristic impedance of the arterial system, which is the pulsatile component of the afterload that is presented to the left ventricle. Furthermore, arterial stiffening increases the velocity at which the pulse wave travels, resulting in an earlier return of the reflected wave from peripheral sites, and hence, suboptimal ventricular-arterial interaction. Given the relationships between arterial stiffness, vascular impedance and wave reflection, it is understandable that arterial stiffness may impact cardiovascular health.
The contention that arterial stiffness is a marker of vascular disease and a risk factor for cardiovascular morbidity and mortality, in adults, is gaining support. In adults, the association of increased arterial stiffness with various pathophysiological conditions has been extensively reviewed.2-5) Importantly, stiffness of central arteries, as assessed by the aortic pulse wave velocity (PWV) and carotid distensibility, has been shown to have an independent predictive value for cardiovascular events in the general adult population,6)7) in elderly,8) and in adults with hypertension,9-11) end-stage renal failure,12-15) and impaired glucose tolerance.16)
Noninvasive methods have been increasingly adopted in both the research and clinical arenas to determine systemic arterial stiffness, and these methods have significantly increased the understanding of the pathophysiological significance. With adoption of these non-invasive methodologies for use in children and adolescents, the phenomenon and significance of arterial stiffening in the young are beginning to unfold. The present article aims to provide an overview of the methods used to assess arterial stiffness in vivo and of the determinants and significance of arterial stiffness in children and adolescents.

Measurement of Arterial Stiffness In Vivo

Noninvasive methods are available for determination of 1) local or cross-sectional stiffness at a particular site in the artery, 2) regional stiffness along the length of an arterial segment, and 3) systemic or whole-body arterial stiffness.

Local arterial stiffness

Local arterial stiffness is ascertained by relating changes in arterial diameter or cross-sectional area to pressure changes at the site of interest. The commonly used indices for quantification of local arterial stiffness are summarized in Table 1.
For superficial arteries including the brachial, femoral and carotid arteries, the diameter and diameter change from end-diastole to end-systole can be assessed by ultrasound (Fig. 1A) and echo-tracking techniques. Compared with two-dimensional ultrasound assessment, echo-tracking permits the tracking of displacement of the anterior and posterior arterial walls with a much higher precision.2)17)18) For deeper arteries, such as the aorta, magnetic resonance imaging19) and transesophageal echocardiography with acoustic quantification20) have been used to determine the change in arterial diameter during the cardiac cycle.
Ideally, local pressure should be measured at the site of diameter measurements. Applanation tonometry (Fig. 1B) allows noninvasive recording of the arterial pressure waveform in the carotid and peripheral conduit arteries.21) The tonometer has the size of a pen, is hand-held and gently compressed against the underlying bone, thus flattening the artery slightly and equalizing the circumferential pressures. The recorded pressure waveform is almost identical to that obtained intra-arterially and can then be calibrated against the cuff mean and diastolic blood pressures of the brachial artery.22)23) Alternatively, the cuff brachial artery pulse pressure has also been commonly used for the calculation of local arterial stiffness indices. Amplification of pulse pressure along the arterial tree, however, constitutes a potential source of error.
Recently, tissue Doppler imaging24) and speckle tracking echocardiography25)26) have been used to assess arterial strain and strain rate as novel indices of cross-sectional arterial stiffness.

Regional arterial stiffness

Measuring the PWV over the segment of interest assesses stiffness along the length of an arterial segment or regional stiffness. PWV is the speed at which the forward pressure or flow wave is transmitted from the aorta through the arterial tree.
The Bramwell and Hill27) equation relates PWV to arterial distensibility: PWV=√(ΔP·V)/ΔVρ=√1/ ρD, where P is pressure, V is volume, ΔP·V/ΔV represents volume elasticity, ρ is density of blood, and D is volume distensibility of the arterial segment. Hence, PWV is related inversely to arterial distensibility; in other words, the stiffer the artery, the faster the PWV. By providing an average stiffness of the arterial segment of interest, PWV may provide a better reflection of the general vascular health.
PWV is determined by dividing the distance of pulse travel, between two sites, by the transit time. As the pulse pressure and flow pulse propagate at the same velocity, the arterial pulse may be registered using pressure-sensitive transducers,28) an oscillometric device,29) applanation tonometry,30) Doppler ultrasound31)32) photoplethysmography,33) and magnetic resonance imaging.34)35) The pulse recording at the two sites can be obtained simultaneously (Fig. 2) or by gating separate recordings to the R wave of the electrocardiogram.
The distance along which the pulse travels is usually estimated by direct superficial measurement between the two pressure transducers or other devices used to register the pulse. Transit time is measured as the time delay between the feet of the proximal and distal pulse waves (Fig. 3). The foot of the pulse wave is used as it is relatively unaffected by wave reflections. A potential source of error is the need to use the nearest superficial arteries as a surrogate site for inaccessible central arteries, and the estimation of the actual distance between the recording sites using surface measurements. Despite these limitations, PWV is probably the most widely used technique for assessment of arterial stiffness.

Systemic arterial stiffness

Pulse contour analysis has been used to assess systemic or whole-body arterial stiffness noninvasively.36-38) One of the methods focuses on the diastolic pressure decay of the radial pulse contour obtained by tonometry. An algorithm is used to determine the best set of values for matching the diastolic contour to a multi-exponential waveform equation. Based on these values, the lumped compliance of the major arteries and that of the small peripheral arteries is estimated. However, the biologic relevance of the derived lumped compliance remains unclear.
The area method has also been used to determine systemic arterial compliance using the formula: compliance= A/{total vascular resistance×(Pes-Pd)}, where A is area under the diastolic portion of the arterial pressure wave from end-systole to end-diastole, Pes is end-systolic pressure, and Pd is end-diastolic pressure.39)40) The pressure readings and waveform are obtained by applanation tonometry over the common carotid artery. The total vascular resistance is calculated as mean blood pressure divided by mean aortic blood flow, the latter obtained by a velocimeter positioned at the suprasternal notch. The area method nonetheless shares a similar concern as aforementioned.

Arterial Stiffening in the Young

Evolution with age

Aortic, upper limb, and lower limb pulse wave velocities increase with age from child- to adulthood.41-43) Notwithstanding the influence of distending pressure on arterial stiffness, previous data did not suggest that the change in PWV with age is entirely due to differences in systemic blood pressure.41)42) With cyclical mechanical stress, fragmentation of the elastin fibres and transfer of stress to the much stiffer collagen fibres inevitably results in the progressive increase in vascular stiffness.44)
Furthermore, studies of developmental changes in arterial structure during childhood have demonstrated progressive increase in intimal and medial thickness after birth.45) Hence, the observed age-related increase in stiffness is likely related to progressive structural changes in the arterial wall during childhood. Interpretation of results obtained from paediatric populations at risk for arterial dysfunction should therefore take into account age-related evolution.

Cardiovascular risk factor

Traditional cardiovascular risk factors46-56) have been associated with arterial stiffening in children and are summarized in Table 2.

Prenatal growth restriction

The 'fetal origins hypothesis'57) proposes that cardiovascular disease originates through adaptation to an adverse environment in utero. These adaptations have been suggested to cause permanent alterations in cardiovascular structure and physiology through the process of programming. Indeed, there is evidence that individuals who are born small may be at risk for arterial dysfunction in child- and adulthood.
In very low birth weight, premature infants, reduced aortic wall distensibility and whole-body compliance have been shown as early as the neonatal period.58) Other studies have demonstrated inverse relationships between systemic arterial stiffness and gestational age59) and birth weight standardized for gestational age.60) In fetuses with umbilical placental insufficiency, an increase in afterload has been shown to result in a decrease in aortic distensibility during the neonatal period.61) Furthermore, reduced compliance of the aorta and conduit arteries of the legs has been shown to occur in adults born small.62)
In monozygotic twins with twin-twin transfusion syndrome, the growth-restricted donor twin has been reported to have increased peripheral conduit arterial stiffness during infancy.63) Such vascular programming has been shown to be ameliorated, albeit not completely abolished, by intrauterine endoscopic laser ablation of placental anastomoses.64) Even in monozygotic twins without twin-twin transfusion syndrome, the twin with the lower birthweight has been found to have higher systolic blood pressure and pulse pressure in childhood.65)
The mechanism whereby low birth weight is associated with increased arterial stiffness in child- and adulthood remains unclear. The reported endothelial dysfunction in individuals born preterm and small-for-gestational age62)66-69) suggests that functional alteration of arterial tone may contribute to an increase in systemic arterial stiffness. Altered haemodynamics in intrauterine growth retardation, which result in preferential perfusion of upper part of body,70) may affect the mechanical properties of the large arteries. Another proposed mechanism is impaired synthesis of elastin in the arterial wall.44)

Vasculitides

Vasculitis is the predominant feature in several childhood diseases. The acute inflammation and subsequent reparative process may lead to replacement of elastic tissue by fibrous scar, thereby potentially altering the mechanical properties of the vessels.
Kawasaki disease, a systemic vasculitis with predilection for children in the East, is the most commonly acquired heart disease in children in developed countries. Apart from the well-documented long-term structural alteration and functional disturbance of coronary arteries,71-75) systemic arterial dysfunction is increasingly documented. Indeed, concerns have been raised regarding the possibility of its predisposition to premature atherosclerosis in adulthood.76-80)
Increased stiffness of the carotid artery81)82) and brachioradial artery80) has been documented in the long-term follow-up of patients with a history of Kawasaki disease. Measurement of aortic input impedance during cardiac catheterization showed reduction in both characteristic impedance and total peripheral arterial compliance, regardless of the persistence of coronary artery aneurysms, suggesting an increase in both central and peripheral arterial stiffness.83) The magnitude of chronic low-grade inflammation, as reflected by elevated high-sensitivity C-reactive protein,84)85) in patients with coronary aneurysm formation has been associated positively with carotid arterial stiffness.84) Additionally, mannose-binding lectin,86) C-reactive protein,87) and tumour necrosis factor-α87) genotype polymorphisms have recently been found to exert modulating effects on long-term systemic arterial stiffness in Kawasaki patients.
In another type of childhood vasculitis, polyarteritis nodosa, the recurrent inflammatory cycles result in multiple stages comprised of acute fibrinoid necrosis and healing fibrotic lesions. While the chronic phenomenon, with recurrent episodes of inflammatory exacerbations, contrasts with the acute vasculitis in Kawasaki disease, stiffening of the peripheral conduit arterial stiffness and its amplification, during episodes of inflammatory exacerbation, are similarly found in polyarteritis nodosa.42)

Vasculopathies

Abnormalities of the arterial vasculature have been described in Marfan and Williams syndromes and in association with a bicuspid aortic valve. Marfan syndrome is caused by a mutation in the gene that encodes fibrillin-1,88) a matrix glycoprotein that is the principal constituent of microfibrils. On the other hand, haploin-sufficiency of the elastin gene has been implicated in the arteriopathy of Williams syndrome.89) Increased aortic stiffness is well documented in patients with Marfan syndrome, as shown by the decreased distensibility and increased stiffness index,90-97) increased PWV,98) and decreased tissue Doppler-derived systolic and diastolic velocities of the aortic wall.99) Importantly, aortic stiffness has been shown to be an independent predictor of progressive aortic dilation100)101) and aortic dissection.101) Beta-blocker therapy98) and angiotensin-converting enzyme inhibition102) appear to reduce aortic stiffness, which may, in turn, slow aortic dilation and delay aortic root replacement.102) Despite a biological basis for abnormal elastic fibres, results of studies exploring arterial elastic properties in patients with Williams syndrome are controversial.103-106) In both children and adults,107) an isolated bicuspid aortic valve is associated with progressive dilation of the ascending aorta and increased aortic stiffness.108)109)

Congenital heart disease

In a variety of congenital heart lesions, medial abnormalities with elastic fibre fragmentation have been identified in intraoperative biopsies and necropsy aortic specimens.110) These congenital heart lesions include tetralogy of Fallot with or without pulmonary atresia, truncus arteriosus, complete transposition of the great arteries, coarctation of the aorta, double-outlet ventricles, and univentricular hearts.
In children and adolescents with tetralogy of Fallot, aortic stiffness has been shown to be increased and related to the aortic root dimensions.111) Additional data suggest that there is preferential stiffening of the central, over peripheral, conduit arteries.112) Importantly, the heart-femoral PWV has been found to be a significant size determinant of the sinotubular junction, suggesting that central arterial stiffening may contribute to progressive aortic root dilation in these patients.
In transposition of the great arteries, patients undergoing two-stage anatomic correction were found to have decreased distensibility of the neoaorta, and this is thought to be related to pulmonary arterial banding.113) Nonetheless, even after one-stage arterial switch operation, impaired distensibility of the neoaorta has similarly been documented.114) Recent studies documented an increased stiffness index of the carotid artery in patients both after atrial and arterial switch operations,115)116) suggesting that impaired elastogenesis may be an intrinsic component of this congenital anomaly.
In the aortic segment proximal to the site of aortic coarctation, increase in collagen and decrease in smooth muscle content have been described.117) Functionally, distensibility of the aortic arch has been shown to be significantly lower than that of the distal thoracic aorta.118) The importance of early coarctation repair on possible prevention of late vascular dysfunction is highlighted by the inverse relationships found between age at repair and stiffness and vascular reactivitiy of the precoarctation arterial segments.118-120) Interestingly, the results of a recent study suggest that impaired elastic properties of the prestenotic aorta may be a primary abnormality as evidenced by an increased ascending aortic stiffness index, even preoperatively, in neonates with coarctation.121)

Systemic childhood diseases

Apart from diseases of the heart and blood vessels, several chronic systemic diseases in childhood have been found to be associated with arterial stiffening (Table 3).122-129)

Functional Implications on Cardiac Performance

Ventricular afterload is increased in the presence of systemic arterial stiffening. To generate the same stroke volume against a stiffened arterial tree, with increased afterload, the systemic ventricle has to generate a higher end-systolic pressure at the expense of greater myocardial oxygen consumption.
Structural adaptation of the left ventricle to increased afterload is also evident in the presence of arterial stiffening. In an otherwise healthy population of adults, measures of arterial stiffness including elastic modulus, distensibility, and PWV have been shown to be significant determinants of left ventricular mass.130)
Arterial stiffening is also associated with alteration of phasic coronary flow pattern.131)132) Early return of the reflected pressure wave, due to a faster PWV, augments central systolic pressure and lowers diastolic coronary perfusion pressure.
The increased myocardial oxygen consumption, left ventricular hypertrophy, and decreased diastolic coronary perfusion pressure predispose the conditions of subendocardial ischemia and interstitial fibrosis, which in turn can impair myocardial relaxation and reduce ventricular compliance.133)134) Indeed, associations between arterial stiffness and left ventricular diastolic dysfunction in adults with hypertension134-137) and diabetes mellitus135)137)138) are recognized. Associations between arterial stiffening and left ventricular systolic function in adults with139) and without135) coronary artery disease have also been found.

Clinical implications on management

Early identification of arterial dysfunction in childhood may provide a window for early intervention. Amelioration of endothelial dysfunction may reduce arterial stiffness through the lowering of smooth muscle tone. The potential beneficial effects on endothelial function of folic acid in children with renal failure,140)141) antioxidant vitamins and statins in those with familial hypercholesterolemia,142-144) vitamin C in those with Kawasaki disease,145) and exercise training in obese children146)147) have been reported. In patients with Marfan syndrome, beta-blocker therapy98) and angiotensin-converting enzyme inhibition102) appear to reduce aortic stiffness.
Lifestyle modification early in life may prevent premature stiffening of arteries. In this regard, there is evidence to suggest a beneficial impact on arterial stiffness by sodium restriction,148) regular exercise,149) intake of fish oil150) and isoflavone,151) and smoking cessation.152) Longitudinal studies are, however, required to determine whether improvement of arterial function in the young will be translated into clinical benefits in adulthood.

Conclusions

With availability of noninvasive technologies for determination of arterial stiffness in children, the significance of the phenomenon of arterial stiffening in the young is becoming better understood. Importantly, even in children and adolescents, accumulating evidence suggests that clinical conditions associated with abnormal functioning of the arterial system may have long-term clinical implications. Further studies to elucidate the underlying mechanisms of arterial stiffening in the young are warranted. Additionally, longitudinal studies are required to clarify whether systemic arterial stiffening tracks from child- to adulthood and whether early implementation of strategies to reduce arterial stiffness may have an impact on long-term cardiovascular health in both healthy and at-risk paediatric populations.

Figures and Tables

Fig. 1
Derivation of local arterial stiffness by measurement of (A) diameter changes in the cardiac cycle using two-dimensional ultrasound, and (B) arterial pressure using applanation tonometry.
kcj-40-153-g001
Fig. 2
Simultaneous registration of arterial pulse waveforms by pressure sensors placed at different parts of body for calculation of pulse transit time.
kcj-40-153-g002
Fig. 3
Derivation of pulse transit time from the feet of the proximal and distal pulse waves.
kcj-40-153-g003
Table 1
Commonly used indices of local or cross-sectional arterial stiffness
kcj-40-153-i001

D: diastolic diameter, ΔD: difference in systolic and diastolic diameter, ln: natural logarithm, ΔP: pressure, Pd: diastolic blood pressure, Ps: systolic blood pressure

Table 2
Traditional cardiovascular risk factors associated with arterial stiffening in childhood
kcj-40-153-i002
Table 3
Systemic childhood conditions associated with arterial stiffening
kcj-40-153-i003

References

1. Laurent S, Hayoz D, Trazzi S, et al. Isobaric compliance of the radial artery is increased in patients with essential hypertension. J Hypertens. 1993. 11:89–98.
2. Laurent S, Cockcroft J, Van Bortel L, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006. 27:2588–2605.
3. Mackenzie IS, Wilkinson IB, Cockcroft JR. Assessment of arterial stiffness in clinical practice. QJM. 2002. 95:67–74.
4. Oliver JJ, Webb DJ. Noninvasive assessment of arterial stiffness and risk of atherosclerotic events. Arterioscler Thromb Vasc Biol. 2003. 23:554–566.
5. Zieman SJ, Melenovsky V, Kass DA. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol. 2005. 25:932–943.
6. Shokawa T, Imazu M, Yamamoto H, et al. Pulse wave velocity predicts cardiovascular mortality: findings from the Hawaii-Los Angeles-Hiroshima study. Circ J. 2005. 69:259–264.
7. Willum-Hansen T, Staessen JA, Torp-Pedersen C, et al. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation. 2006. 113:664–670.
8. Sutton-Tyrrell K, Najjar SS, Boudreau RM, et al. Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation. 2005. 111:3384–3390.
9. Boutouyrie P, Tropeano AI, Asmar R, et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension. 2002. 39:10–15.
10. Laurent S, Boutouyrie P, Asmar R, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001. 37:1236–1241.
11. Laurent S, Katsahian S, Fassot C, et al. Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke. 2003. 34:1203–1206.
12. Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar ME, London GM. Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease. Hypertension. 1998. 32:570–574.
13. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness on survival in end-stage renal disease. Circulation. 1999. 99:2434–2439.
14. Shoji T, Emoto M, Shinohara K, et al. Diabetes mellitus, aortic stiffness, and cardiovascular mortality in end-stage renal disease. J Am Soc Nephrol. 2001. 12:2117–2124.
15. Barenbrock M, Kosch M, Joster E, Kisters K, Rahn KH, Hausberg M. Reduced arterial distensibility is a predictor of cardiovascular disease in patients after renal transplantation. J Hypertens. 2002. 20:79–84.
16. Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation. 2002. 106:2085–2090.
17. Tardy Y, Meister JJ, Perret F, Brunner HR, Arditi M. Non-invasive estimate of the mechanical properties of peripheral arteries from ultrasonic and photoplethysmographic measurements. Clin Phys Physiol Meas. 1991. 12:39–54.
18. Hoeks AP, Brands PJ, Smeets FA, Reneman RS. Assessment of the distensibility of superficial arteries. Ultrasound Med Biol. 1990. 16:121–128.
19. Resnick LM, Militianu D, Cunnings AJ, Pipe JG, Evelhoch JL, Soulen RL. Direct magnetic resonance determination of aortic distensibility in essential hypertension: relation to age, abdominal visceral fat, and in situ intracellular free magnesium. Hypertension. 1997. 30:654–659.
20. Kang SM, Ha JW, Chung N, et al. Assessment of elastic properties of the descending thoracic aorta by transesophageal echocardiography with acoustic quantification in patients with a stroke. Echocardiography. 2000. 17:713–720.
21. Benetos A, Laurent S, Hoeks AP, Boutouyrie PH, Safar ME. Arterial alterations with aging and high blood pressure: a noninvasive study of carotid and femoral arteries. Arterioscler Thromb. 1993. 13:90–97.
22. Kelly R, Fitchett D. Noninvasive determination of aortic input impedance and external left ventricular power output: a validation and repeatability study of a new technique. J Am Coll Cardiol. 1992. 20:952–963.
23. Verbeke F, Segers P, Heireman S, Vanholder R, Verdonck P, Van Bortel LM. Noninvasive assessment of local pulse pressure: importance of brachial-to-radial pressure amplification. Hypertension. 2005. 46:244–248.
24. Kawasaki T, Fukuda S, Shimada K, et al. Direct measurement of wall stiffness for carotid arteries by ultrasound strain imaging. J Am Soc Echocardiogr. 2009. 22:1389–1395.
25. Oishi Y, Mizuguchi Y, Miyoshi H, Iuchi A, Nagase N, Oki T. A novel approach to assess aortic stiffness related to changes in aging using a two-dimensional strain imaging. Echocardiography. 2008. 25:941–945.
26. Kim KH, Park JC, Yoon HJ, et al. Usefulness of aortic strain analysis by velocity vector imaging as a new echocardiographic measure of arterial stiffness. J Am Soc Echocardiogr. 2009. 22:1382–1388.
27. Bramwell JC, Hill AV. Velocity of transmission of the pulse wave. Lancet. 1992. 1:891–892.
28. Asmar R, Benetos A, Topouchian J, et al. Assessment of arterial distensibility by automatic pulse wave velocity measurement: validation and clinical application studies. Hypertension. 1995. 26:485–490.
29. Cortez-Cooper MY, Supak JA, Tanaka H. A new device for automatic measurements of arterial stiffness and ankle-brachial index. Am J Cardiol. 2003. 91:1519–1522. A9.
30. Wilkinson IB, Fuchs SA, Jansen IM, et al. Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. J Hypertens. 1998. 16:2079–2084.
31. Kontis S, Gosling RG. On-line Doppler ultrasound measurement of aortic compliance and its repeatability in normal subjects. Clin Phys Physiol Meas. 1989. 10:127–135.
32. Wright JS, Cruickshank JK, Kontis S, Dore C, Gosling RG. Aortic compliance measured by non-invasive Doppler ultrasound: description of a method and its reproducibility. Clin Sci. 1990. 78:463–468.
33. Loukougeorgakis S, Dawson R, Phillips N, et al. Validation of a device to measure arterial pulse wave velocity by a photoplethysmographic method. Physiol Meas. 2002. 23:581–596.
34. Mohiaddin RH, Firmin DN, Longmore DB. Age-related changes of human aortic flow wave velocity measured noninvasively by magnetic resonance imaging. J Appl Physiol. 1993. 74:492–497.
35. Stevanov M, Baruthio J, Gounot D, Grucker D. In vitro validation of MR measurements of arterial pulse-wave velocity in the presence of reflected waves. J Magn Reson Imaging. 2001. 14:120–127.
36. Cohn JN, Finkelstein S, McVeigh G, et al. Noninvasive pulse wave analysis for the early detection of vascular disease. Hypertension. 1995. 26:503–508.
37. McVeigh GE, Bratteli CW, Morgan DJ, et al. Age-related abnormalities in arterial compliance identified by pressure pulse contour analysis: aging and arterial compliance. Hypertension. 1999. 33:1392–1398.
38. McVeigh GE. Pulse waveform analysis and arterial wall properties. Hypertension. 2003. 41:1010–1011.
39. Liu Z, Brin KP, Yin FC. Estimation of total arterial compliance: an improved method and evaluation of current methods. Am J Physiol. 1986. 251:H588–H600.
40. Marcus RH, Korcarz C, McCray G, et al. Noninvasive method for determination of arterial compliance using Doppler echocardiography and subclavian pulse tracings: validation and clinical application of a physiological model of the circulation. Circulation. 1994. 89:2688–2699.
41. Avolio AP, Chen SG, Wang RP, Zhang CL, Li MF, O'Rourke MF. Effects of aging on changing arterial compliance and left ventricular load in a northern Chinese urban community. Circulation. 1983. 68:50–58.
42. Cheung YF, Brogan PA, Pilla CB, Dillon MJ, Redington AN. Arterial distensibility in children and teenagers: normal evolution and the effect of childhood vasculitis. Arch Dis Child. 2002. 87:348–351.
43. Senzaki H, Akagi M, Hishi T, et al. Age-associated changes in arterial elastic properties in children. Eur J Pediatr. 2002. 161:547–551.
44. Martyn CN, Greenwald SE. Impaired synthesis of elastin in walls of aorta and large conduit arteries during early development as an initiating event in pathogenesis of systemic hypertension. Lancet. 1997. 350:953–955.
45. Glukhova MA, Frid MG, Koteliansky VE. Phenotypic changes of human aortic smooth muscle cells during development and in the adult vessel. Am J Physiol. 1991. 261:4 Suppl. 78–80.
46. Levent E, Goksen D, Ozyurek AR, et al. Stiffness of the abdominal aorta in obese children. J Pediatr Endocrinol Metab. 2002. 15:405–409.
47. Iannuzzi A, Licenziati MR, Acampora C, et al. Preclinical changes in the mechanical properties of abdominal aorta in obese children. Metabolism. 2004. 53:1243–1246.
48. Tounian P, Aggoun Y, Dubern B, et al. Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: a prospective study. Lancet. 2001. 358:1400–1404.
49. Whincup PH, Gilg JA, Donald AE, et al. Arterial distensibility in adolescents: the influence of adiposity, the metabolic syndrome, and classic risk factors. Circulation. 2005. 112:1789–1797.
50. Aggoun Y, Bonnet D, Sidi D, et al. Arterial mechanical changes in children with familial hypercholesterolemia. Arterioscler Thromb Vasc Biol. 2000. 20:2070–2075.
51. Virkola K, Pesonen E, Akerblom HK, Siimes MA. Cholesterol and carotid artery wall in children and adolescents with familial hypercholesterolaemia: a controlled study by ultrasound. Acta Paediatr. 1997. 86:1203–1207.
52. Leeson CP, Whincup PH, Cook DG, et al. Cholesterol and arterial distensibility in the first decade of life: a population-based study. Circulation. 2000. 101:1533–1538.
53. Haller MJ, Samyn M, Nichols WW, et al. Radial artery tonometry demonstrates arterial stiffness in children with type 1 diabetes. Diabetes Care. 2004. 27:2911–2917.
54. Hopkins KD, Lehmann ED, Jones RL, Turay RC, Gosling RG. A family history of NIDDM is associated with decreased aortic distensibility in normal healthy young adult subjects. Diabetes Care. 1996. 19:501–503.
55. McEleavy OD, McCallum RW, Petrie JR, et al. Higher carotidradial pulse wave velocity in healthy offspring of patients with Type 2 diabetes. Diabet Med. 2004. 21:262–266.
56. Schack-Nielsen L, Molgaard C, Larsen D, Martyn C, Michaelsen KF. Arterial stiffness in 10-year-old children: current and early determinants. Br J Nutr. 2005. 94:1004–1011.
57. Barker DJ. Fetal origins of coronary heart disease. BMJ. 1995. 311:171–174.
58. Tauzin L, Rossi P, Giusano B, et al. Characteristics of arterial stiffness in very low birth weight premature infants. Pediatr Res. 2006. 60:592–596.
59. Oren A, Vos LE, Bos WJ, et al. Gestational age and birth weight in relation to aortic stiffness in healthy young adults: two separate mechanisms? Am J Hypertens. 2003. 16:76–79.
60. Cheung YF, Wong KY, Lam BC, Tsoi NS. Relation of arterial stiffness with gestational age and birth weight. Arch Dis Child. 2004. 89:217–221.
61. Akira M, Yoshiyuki S. Placental circulation, fetal growth, and stiffness of the abdominal aorta in newborn infants. J Pediatr. 2006. 148:49–53.
62. Martyn CN, Barker DJ, Jespersen S, Greenwald S, Osmond C, Berry C. Growth in utero, adult blood pressure, and arterial compliance. Br Heart J. 1995. 73:116–121.
63. Cheung YF, Taylor MJ, Fisk NM, Redington AN, Gardiner HM. Fetal origins of reduced arterial distensibility in the donor twin in twin-twin transfusion syndrome. Lancet. 2000. 355:1157–1158.
64. Gardiner HM, Taylor MJ, Karatza A, et al. Twin-twin transfusion syndrome: the influence of intrauterine laser photocoagulation on arterial distensibility in childhood. Circulation. 2003. 107:1906–1911.
65. Halvorsen CP, Andolf E, Hu J, Pilo C, Winbladh B, Norman M. Discordant twin growth in utero and differences in blood pressure and endothelial function at 8 years of age. J Intern Med. 2006. 259:155–163.
66. Martin H, Gazelius B, Norman M. Impaired acetylcholine-induced vascular relaxation in low birth weight infants: implications for adult hypertension? Pediatr Res. 2000. 47:457–462.
67. Leeson CP, Whincup PH, Cook DG, et al. Flow-mediated dilation in 9- to 11-year-old children: the influence of intrauterine and childhood factors. Circulation. 1997. 96:2233–2238.
68. Leeson CP, Kattenhorn M, Morley R, Lucas A, Deanfield JE. Impact of low birth weight and cardiovascular risk factors on endothelial function in early adult life. Circulation. 2001. 103:1264–1268.
69. Singhal A, Kattenhorn M, Cole TJ, Deanfield J, Lucas A. Preterm birth, vascular function, and risk factors for atherosclerosis. Lancet. 2001. 358:1159–1160.
70. Akalin-Sel T, Campbell S. Understanding the pathophysiology of intra-uterine growth retardation: the role of the 'lower limb reflex' in redistribution of blood flow. Eur J Obstet Gynecol Reprod Biol. 1992. 46:79–86.
71. Kato H, Sugimura T, Akagi T, et al. Long-term consequences of Kawasaki disease: a 10- to 21-year follow-up study of 594 patients. Circulation. 1996. 94:1379–1385.
72. Sugimura T, Kato H, Inoue O, Takagi J, Fukuda T, Sato N. Vasodilatory response of the coronary arteries after Kawasaki disease: evaluation by intracoronary injection of isosorbide dinitrate. J Pediatr. 1992. 121:684–688.
73. Iemura M, Ishii M, Sugimura T, Akagi T, Kato H. Long term consequences of regressed coronary aneurysms after Kawasaki disease: vascular wall morphology and function. Heart. 2000. 83:307–311.
74. Sugimura T, Kato H, Inoue O, et al. Intravascular ultrasound of coronary arteries in children: assessment of the wall morphology and the lumen after Kawasaki disease. Circulation. 1994. 89:258–265.
75. Furuyama H, Odagawa Y, Katoh C, et al. Assessment of coronary function in children with a history of Kawasaki disease using (15) O-water positron emission tomography. Circulation. 2002. 105:2878–2884.
76. Kato H, Inoue O, Kawasaki T, Fujiwara H, Watanabe T, Toshima H. Adult coronary artery disease probably due to childhood Kawasaki disease. Lancet. 1992. 340:1127–1129.
77. Burns JC, Shike H, Gordon JB, Malhotra A, Schoenwetter M, Kawasaki T. Sequelae of Kawasaki disease in adolescents and young adults. J Am Coll Cardiol. 1996. 28:253–257.
78. Ishiwata S, Fuse K, Nishiyama S, Nakanishi S, Watanabe Y, Seki A. Adult coronary artery disease secondary to Kawasaki disease in childhood. Am J Cardiol. 1992. 69:692–694.
79. Silva AA, Maeno Y, Hashmi A, Smallhorn JF, Silverman ED, McCrindle BW. Cardiovascular risk factors after Kawasaki disease: a case-control study. J Pediatr. 2001. 138:400–405.
80. Cheung YF, Yung TC, Tam SC, Ho MH, Chau AK. Novel and traditional cardiovascular risk factors in children after Kawasaki disease: implications for premature atherosclerosis. J Am Coll Cardiol. 2004. 43:120–124.
81. Noto N, Okada T, Yamasuge M, et al. Noninvasive assessment of the early progression of atherosclerosis in adolescents with Kawasaki disease and coronary artery lesions. Pediatrics. 2001. 107:1095–1099.
82. Cheung YF, Wong SJ, Ho MH. Relationship between carotid intima-media thickness and arterial stiffness in children after Kawasaki disease. Arch Dis Child. 2007. 92:43–47.
83. Senzaki H, Chen CH, Ishido H, et al. Arterial hemodynamics in patients after Kawasaki disease. Circulation. 2005. 111:2119–2125.
84. Cheung YF, Ho MH, Tam SC, Yung TC. Increased high sensitivity C reactive protein concentrations and increased arterial stiffness in children with a history of Kawasaki disease. Heart. 2004. 90:1281–1285.
85. Mitani Y, Sawada H, Hayakawa H, et al. Elevated levels of high-sensitivity C-reactive protein and serum amyloid-A late after Kawasaki disease: association between inflammation and late coronary sequelae in Kawasaki disease. Circulation. 2005. 111:38–43.
86. Cheung YF, Ho MH, Ip WK, Fok SF, Yung TC, Lau YL. Modulating effects of mannose binding lectin genotype on arterial stiffness in children after Kawasaki disease. Pediatr Res. 2004. 56:591–596.
87. Cheung YF, Huang GY, Chen SB, et al. Inflammatory gene polymorphisms and susceptibility to Kawasaki disease and its arterial sequelae. Pediatrics. 2008. 122:e608–e614.
88. Dietz HC, Cutting GR, Pyeritz RE, et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature. 1991. 352:337–339.
89. Tassabehji M, Metcalfe K, Donnai D, et al. Elastin: genomic structure and point mutations in patients with supravalvular aortic stenosis. Hum Mol Genet. 1997. 6:1029–1036.
90. Yin FC, Brin KP, Ting CT, Pyeritz RE. Arterial hemodynamic indexes in Marfan's syndrome. Circulation. 1989. 79:854–862.
91. Jeremy RW, Huang H, Hwa J, McCarron H, Hughes CF, Richards JG. Relation between age, arterial distensibility, and aortic dilatation in the Marfan syndrome. Am J Cardiol. 1994. 74:369–373.
92. Haouzi A, Berglund H, Pelikan PC, Maurer G, Siegel RJ. Heterogeneous aortic response to acute beta-adrenergic blockade in Marfan syndrome. Am Heart J. 1997. 133:60–63.
93. Hirata K, Triposkiadis F, Sparks E, Bowen J, Wooley CF, Boudoulas H. The Marfan syndrome: abnormal aortic elastic properties. J Am Coll Cardiol. 1991. 18:57–63.
94. Reed CM, Fox ME, Alpert BS. Aortic biomechanical properties in pediatric patients with the Marfan syndrome, and the effects of atenolol. Am J Cardiol. 1993. 71:606–608.
95. Sonesson B, Hansen F, Lanne T. Abnormal mechanical properties of the aorta in Marfan's syndrome. Eur J Vasc Surg. 1994. 8:595–601.
96. Adams JN, Brooks M, Redpath TW, et al. Aortic distensibility and stiffness index measured by magnetic resonance imaging in patients with Marfan's syndrome. Br Heart J. 1995. 73:265–269.
97. Franke A, Muhler EG, Klues HG, et al. Detection of abnormal aortic elastic properties in asymptomatic patients with Marfan syndrome by combined transoesophageal echocardiography and acoustic quantification. Heart. 1996. 75:307–311.
98. Groenink M, de Roos A, Mulder BJ, Spaan JA, van der Wall EE. Changes in aortic distensibility and pulse wave velocity assessed with magnetic resonance imaging following beta-blocker therapy in the Marfan syndrome. Am J Cardiol. 1998. 82:203–208.
99. Harada K, Yasuoka K, Shimada Y. Usefulness of tissue doppler imaging for assessing aortic wall stiffness in children with the Marfan syndrome. Am J Cardiol. 2004. 93:1072–1075.
100. Nollen GJ, Groenink M, Tijssen JG, Van Der Wall EE, Mulder BJ. Aortic stiffness and diameter predict progressive aortic dilatation in patients with Marfan syndrome. Eur Heart J. 2004. 25:1146–1152.
101. Vitarelli A, Conde Y, Cimino E, et al. Aortic wall mechanics in the Marfan syndrome assessed by transesophageal tissue Doppler echocardiography. Am J Cardiol. 2006. 97:571–577.
102. Yetman AT, Bornemeier RA, McCrindle BW. Usefulness of enalapril versus propranolol or atenolol for prevention of aortic dilation in patients with the Marfan syndrome. Am J Cardiol. 2005. 95:1125–1127.
103. Wessel A, Pankau R, Berdau W, Lons P. Aortic stiffness with the Williams-Beuren syndrome. Pediatr Cardiol. 1997. 18:244.
104. Salaymeh KJ, Banerjee A. Evaluation of arterial stiffness in children with Williams syndrome: does it play a role in evolving hypertension? Am Heart J. 2001. 142:549–555.
105. Aggoun Y, Sidi D, Levy BI, Lyonnet S, Kachaner J, Bonnet D. Mechanical properties of the common carotid artery in Williams syndrome. Heart. 2000. 84:290–293.
106. Lacolley P, Boutouyrie P, Glukhova M, et al. Disruption of the elastin gene in adult Williams syndrome is accompanied by a paradoxical reduction in arterial stiffness. Clin Sci. 2002. 103:21–29.
107. Holmes KW, Lehmann CU, Dalal D, et al. Progressive dilation of the ascending aorta in children with isolated bicuspid aortic valve. Am J Cardiol. 2007. 99:978–983.
108. Nistri S, Sorbo MD, Basso C, Thiene G. Bicuspid aortic valve: abnormal aortic elastic properties. J Heart Valve Dis. 2002. 11:369–373. discussion 373-4.
109. Schaefer BM, Lewin MB, Stout KK, Byers PH, Otto CM. Usefulness of bicuspid aortic valve phenotype to predict elastic properties of the ascending aorta. Am J Cardiol. 2007. 99:686–690.
110. Niwa K, Perloff JK, Bhuta SM, et al. Structural abnormalities of great arterial walls in congenital heart disease: light and electron microscopic analyses. Circulation. 2001. 103:393–400.
111. Chong WY, Wong WH, Chiu CS, Cheung YF. Aortic root dilation and aortic elastic properties in children after repair of tetralogy of Fallot. Am J Cardiol. 2006. 97:905–909.
112. Cheung YF, Ou X, Wong SJ. Central and peripheral arterial stiffness in patients after surgical repair of tetralogy of Fallot: implications for aortic root dilatation. Heart. 2006. 92:1827–1830.
113. Sievers HH, Lange PE, Arensman FW, et al. Influence of two-stage anatomic correction on size and distensibility of the anatomic pulmonary/functional aortic root in patients with simple transposition of the great arteries. Circulation. 1984. 70:202–208.
114. Murakami T, Nakazawa M, Momma K, Imai Y. Impaired distensibility of neoaorta after arterial switch procedure. Ann Thorac Surg. 2000. 70:1907–1910.
115. Mersich B, Studinger P, Lenard Z, Kadar K, Kollai M. Transposition of great arteries is associated with increased carotid artery stiffness. Hypertension. 2006. 47:1197–1202.
116. Pinter A, Laszlo A, Mersich B, Kadar K, Kollai M. Adaptation of baroreflex function to increased carotid artery stiffening in patients with transposition of great arteries. Clin Sci. 2007. 113:41–46.
117. Sehested J, Baandrup U, Mikkelsen E. Different reactivity and structure of the prestenotic and poststenotic aorta in human coarctation: implications for baroreceptor function. Circulation. 1982. 65:1060–1065.
118. Brili S, Dernellis J, Aggeli C, et al. Aortic elastic properties in patients with repaired coarctation of aorta. Am J Cardiol. 1998. 82:1140–1143. A10.
119. de Divitiis M, Pilla C, Kattenhorn M, et al. Vascular dysfunction after repair of coarctation of the aorta: impact of early surgery. Circulation. 2001. 104:12 Suppl 1. I165–I170.
120. Heger M, Willfort A, Neunteufl T, et al. Vascular dysfunction after coarctation repair is related to the age at surgery. Int J Cardiol. 2005. 99:295–299.
121. Vogt M, Kuhn A, Baumgartner D, et al. Impaired elastic properties of the ascending aorta in newborns before and early after successful coarctation repair: proof of a systemic vascular disease of the prestenotic arteries? Circulation. 2005. 111:3269–3273.
122. Argyropoulou MI, Kiortsis DN, Daskas N, et al. Distensibility and pulse wave velocity of the thoracic aorta in patients with juvenile idiopathic arthritis: an MRI study. Clin Exp Rheumatol. 2003. 21:794–797.
123. Chow PC, Ho MH, Lee TL, Lau YL, Cheung YF. Relation of arterial stiffness to left ventricular structure and function in adolescents and young adults with pediatric-onset systemic lupus erythematosus. J Rheumatol. 2007. 34:1345–1352.
124. Bonnet D, Aggoun Y, Szezepanski I, Bellal N, Blanche S. Arterial stiffness and endothelial dysfunction in HIV-infected children. AIDS. 2004. 18:1037–1041.
125. Covic A, Mardare N, Gusbeth-Tatomir P, et al. Increased arterial stiffness in children on haemodialysis. Nephrol Dial Transplant. 2006. 21:729–735.
126. Mitsnefes MM, Kimball TR, Witt SA, Glascock BJ, Khoury PR, Daniels SR. Abnormal carotid artery structure and function in children and adolescents with successful renal transplantation. Circulation. 2004. 110:97–101.
127. Cheung YF, Chan GC, Ha SY. Arterial stiffness and endothelial function in patients with beta-thalassemia major. Circulation. 2002. 106:2561–2566.
128. Ulger Z, Aydinok Y, Gurses D, Levent E, Ozyurek AR. Stiffness of the abdominal aorta in beta-thalassemia major patients related with body iron load. J Pediatr Hematol Oncol. 2006. 28:647–652.
129. Kwok KL, Ng DK, Cheung YF. BP and arterial distensibility in children with primary snoring. Chest. 2003. 123:1561–1566.
130. Chen CH, Ting CT, Lin SJ, et al. Which arterial and cardiac parameters best predict left ventricular mass? Circulation. 1998. 98:422–428.
131. Saeki A, Recchia F, Kass DA. Systolic flow augmentation in hearts ejecting into a model of stiff aging vasculature: influence on myocardial perfusion-demand balance. Circ Res. 1995. 76:132–141.
132. Kass DA. Age-related changes in venticular-arterial coupling: pathophysiologic implications. Heart Fail Rev. 2002. 7:51–62.
133. O'Rourke MF. Diastolic heart failure, diastolic left ventricular dysfunction and exercise intolerance. J Am Coll Cardiol. 2001. 38:803–805.
134. Mottram PM, Haluska BA, Leano R, Carlier S, Case C, Marwick TH. Relation of arterial stiffness to diastolic dysfunction in hypertensive heart disease. Heart. 2005. 91:1551–1556.
135. Vinereanu D, Nicolaides E, Boden L, Payne N, Jones CJ, Fraser AG. Conduit arterial stiffness is associated with impaired left ventricular subendocardial function. Heart. 2003. 89:449–450.
136. Yambe M, Tomiyama H, Hirayama Y, et al. Arterial stiffening as a possible risk factor for both atherosclerosis and diastolic heart failure. Hypertens Res. 2004. 27:625–631.
137. Eren M, Gorgulu S, Uslu N, Celik S, Dagdeviren B, Tezel T. Relation between aortic stiffness and left ventricular diastolic function in patients with hypertension, diabetes, or both. Heart. 2004. 90:37–43.
138. Loimaala A, Groundstroem K, Majahalme S, Nenonen A, Vuori I. Impaired myocardial function in newly onset type 2 diabetes associates with arterial stiffness. Eur J Echocardiogr. 2006. 7:341–347.
139. Sakuragi S, Iwasaki J, Tokunaga N, Hiramatsu S, Ohe T. Aortic stiffness is an independent predictor of left ventricular function in patients with coronary heart disease. Cardiology. 2005. 103:107–112.
140. Bennett-Richards K, Kattenhorn M, Donald A, et al. Does oral folic acid lower total homocysteine levels and improve endothelial function in children with chronic renal failure? Circulation. 2002. 105:1810–1815.
141. Bennett-Richards KJ, Kattenhorn M, Donald AE, et al. Oral Larginine does not improve endothelial dysfunction in children with chronic renal failure. Kidney Int. 2002. 62:1372–1378.
142. Mietus-Snyder M, Malloy MJ. Endothelial dysfunction occurs in children with two genetic hyperlipidemias: improvement with antioxidant vitamin therapy. J Pediatr. 1998. 133:35–40.
143. de Jongh S, Lilien MR, Bakker HD, Hutten BA, Kastelein JJ, Stroes ES. Family history of cardiovascular events and endothelial dysfunction in children with familial hypercholesterolemia. Atherosclerosis. 2002. 163:193–197.
144. Engler MM, Engler MB, Malloy MJ, et al. Antioxidant vitamins C and E improve endothelial function in children with hyperlipidemia: Endothelial Assessment of Risk from Lipids in Youth (EARLY) Trial. Circulation. 2003. 108:1059–1063.
145. Deng YB, Li TL, Xiang HJ, Chang Q, Li CL. Impaired endothelial function in the brachial artery after Kawasaki disease and the effects of intravenous administration of vitamin C. Pediatr Infect Dis J. 2003. 22:34–39.
146. Woo KS, Chook P, Yu CW, et al. Effects of diet and exercise on obesity-related vascular dysfunction in children. Circulation. 2004. 109:1981–1986.
147. Watts K, Beye P, Siafarikas A, et al. Exercise training normalizes vascular dysfunction and improves central adiposity in obese adolescents. J Am Coll Cardiol. 2004. 43:1823–1827.
148. Gates PE, Tanaka H, Hiatt WR, Seals DR. Dietary sodium restriction rapidly improves large elastic artery compliance in older adults with systolic hypertension. Hypertension. 2004. 44:35–41.
149. Tanaka H, Dinenno FA, Monahan KD, Clevenger CM, DeSouza CA, Seals DR. Aging, habitual exercise, and dynamic arterial compliance. Circulation. 2000. 102:1270–1275.
150. Nestel P, Shige H, Pomeroy S, Cehun M, Abbey M, Raederstorff D. The n-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid increase systemic arterial compliance in humans. Am J Clin Nutr. 2002. 76:326–330.
151. Teede HJ, McGrath BP, DeSilva L, Cehun M, Fassoulakis A, Nestel PJ. Isoflavones reduce arterial stiffness: a placebo-controlled study in men and postmenopausal women. Arterioscler Thromb Vasc Biol. 2003. 23:1066–1071.
152. Jatoi NA, Jerrard-Dunne P, Feely J, Mahmud A. Impact of smoking and smoking cessation on arterial stiffness and aortic wave reflection in hypertension. Hypertension. 2007. 49:981–985.
TOOLS
Similar articles